Source:http://linkedlifedata.com/resource/pubmed/id/19130618
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2009-5-18
|
pubmed:abstractText |
Positron emission tomography (PET) is a nuclear imaging technique providing noninvasive, three-dimensional, whole-body, quantitative images. The primary use of PET is in tumor detection and staging. More recently, it has been shown to be of value in assessing patients with inflammatory processes. To date the role of PET in the management of patients with inflammatory bowel disease (IBD) has not been defined.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1536-4844
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
951-8
|
pubmed:dateRevised |
2010-3-28
|
pubmed:meshHeading | |
pubmed:year |
2009
|
pubmed:articleTitle |
Role of PET and combination PET/CT in the evaluation of patients with inflammatory bowel disease.
|
pubmed:affiliation |
Department of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.
|
pubmed:publicationType |
Journal Article,
Review
|